NAVIDEA BIOPHARMACEUTICALS, INC. Convertible Notes Payable
NAVIDEA BIOPHARMACEUTICALS, INC. had Convertible Notes Payable of $6.40 million as of 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2012-11-13
- 2012-09-30: Convertible Notes Payable $6.40M.
| Period end | Convertible Notes Payable |
|---|---|
| 2012-09-30 | $6.40M 10-Q · filed 2012-11-13 |